Statement of Support for the NAC Statement:
"As a provincial advisory committee, the BC Transfusion Medicine Advisory Group (TMAG) agrees with and endorses the Canadian National Advisory Committee on Blood & Blood Products (NAC) statement regarding use of special blood products to reverse direct thrombin inhibitors or direct factor Xa inhibitors".

NAC Statement:
"At this time, there is insufficient evidence available to allow the National Advisory Committee on Blood & Blood Products (NAC) to develop a recommendation for the use of prothrombin complex concentrates, FEIBA or recombinant Factor VIIa in the reversal of Direct Thrombin Inhibitors or Direct Factor Xa Inhibitors."